ECETOC Task Force reports on thresholds in chemical respiratory sensitisation
In common with all forms of allergic disease, chemical respiratory allergy develops in two phases. In the first phase, exposure to the inducing chemical allergen, via a relevant route, will cause immunological priming resulting in sensitisation of the respiratory tract. In the second phase, the now sensitised subject responds more vigorously if the same allergen is encountered again: the subject has become ‘sensitised’. Following inhalation exposure of the sensitised subject to the same chemical allergen, an inflammatory response will be provoked in the airways that in turn drives allergic disease.
The analyses by the Task Force have revealed that the acquisition of sensitisation of the respiratory tract to chemicals is dose-dependent and that thresholds do exist. However it is commonly difficult to define exactly what levels of exposure will be required for sensitisation to develop. It is clear that in some circumstances it may be possible to use occupational exposure data to derive levels of workplace exposure that are safe. However, the Task Force highlights the fact that there remains a need to develop improved methods for hazard characterisation.
Original publication
Other news from the department science
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.